In March 2013, the Argus 2 was approved by the FDA for use in the United States and has the capacity to restore functionalvision from people suffering from blindness.
This research provides additional evidence that our subretinal implant technology can help some patients with retinal degeneration regain functionalvision and does so in a way that does not require externally visible equipment.
Having started as an apprentice in the shoe industry at age 17, he had a clear vision, namely to make functional, comfortable shoes designed to fit the foot.